Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein

References

• Bai, L., Chen, J., McEachern, D., Liu, L., Zhou, H., Aguilar, A., & Wang, S. (2014). BM-1197: A novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression In vivo. PLoS ONE, 9, e99404. doi:10.1371/journal.pone.0099404
   PubMed Web of Science ®Google Scholar
• Balasubramanian, P. K., Balupuri, A., Kothandan, G., & Cho, S. J. (2014). In silico study of 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl) ethanones derivatives as CCR1 antagonist: Homology modeling, docking and 3D-QSAR approach. Bioorganic & Medicinal Chemistry Letters, 24, 928–933. doi:10.1016/j.bmcl.2013.12.065
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Janežič, D., & Karplus, M. (1995). Harmonic analysis of large systems. I. Methodology. Journal of Computational Chemistry, 16, 1522–1542. doi:10.1002/jcc.540161209
   Web of Science ®Google Scholar
• Case, D. A., Betz, R. M., Botello-Smith, W., Cerutti, D. S., Cheatham, T. E., I., Darden, T. A., … Kollman, P. A. (2016). AMBER 16. San Francisco, CA: University of California.
   Google Scholar
• Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26, 1668–1688. doi:10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Cerutti, D. S., Duke, R. E., Darden, T. A., & Lybrand, T. P. (2009). Staggered Mesh Ewald: An extension of the smooth particle-Mesh Ewald method adding great versatility. Journal of Chemical Theory and Computation, 5, 2322–2338. doi:10.1021/ct9001015
   PubMed Web of Science ®Google Scholar
• Chan, S. L., & Yu, V. C. (2004). Proteins Of The Bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities. Clinical and Experimental Pharmacology and Physiology, 31, 119–128. doi:10.1111/j.1440-1681.2004.03975.x
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle Mesh Ewald – an N.Log(N) method for Ewald Sums in large systems. The Journal of Chemical Physics, 98, 10089–10092. doi:10.1063/1.464397
   Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647–671. doi:10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Dutta, S., Gullá, S., Chen, T. S., Fire, E., Grant, R. A., & Keating, A. E. (2010). Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. Journal of Molecular Biology, 398, 747–762. doi:10.1016/j.jmb.2010.03.058
   PubMed Web of Science ®Google Scholar
• Evans, D. A. (2014). History of the Harvard chemdraw project. Angewandte Chemie International Edition, 53, 11140–11145. doi:10.1002/anie.201405820
   PubMed Web of Science ®Google Scholar
• Feller, S. E., Zhang, Y. H., Pastor, R. W., & Brooks, B. R. (1995). Constant pressure molecular dynamics simulation: The Langevin piston method. The Journal of Chemical Physics, 103, 4613–4621. doi:10.1063/1.470648
   Web of Science ®Google Scholar
• Feng, Y., Ding, X., Chen, T., Chen, L., Liu, F., Jia, X., … Liu, D. (2010). Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors. Journal of Medicinal Chemistry, 53, 3465–3479. doi:10.1021/jm901004c
   PubMed Web of Science ®Google Scholar
• Gilson, M. K., Sharp, K. A., & Honig, B. H. (1998). Calculating the electrostatic potential of molecules in solution: Method and error assessment. Journal of Computational Chemistry, 9, 327–335. doi:10.1002/jcc.540090407
   Web of Science ®Google Scholar
• Hennessy, E. J. (2016). Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity. Bioorganic & Medicinal Chemistry Letters, 26, 2105–2114. doi:10.1016/j.bmcl.2016.03.032
   PubMed Web of Science ®Google Scholar
• Hockenbery, D. M., Giedt, C. D., O’Neill, J. W., Manion, M. K., & Banker, D. E. (2002). Mitochondria and apoptosis: New therapeutic targets. Advances in Cancer Research, 85, 203–242. doi:10.1016/S0065-230X(02)85007-2
   PubMed Web of Science ®Google Scholar
• Koshy, C., Parthiban, M., & Sowdhamini, R. (2010). 100 ns molecular dynamics simulations to study intramolecular conformational changes in bax. Journal of Biomolecular Structure and Dynamics, 28, 71–83. doi:10.1080/07391102.2010.10507344
   PubMed Web of Science ®Google Scholar
• Kumari, M., Chandra, S., Tiwari, N., & Subbarao, N. (2016). 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum. BMC Structural Biology, 16, 1. doi:10.1186/s12900-016-0063-7
   PubMed Web of Science ®Google Scholar
• Lama, D., & Sankararamakrishnan, R. (2011). Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: Relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X-L. Journal of Computer-Aided Molecular Design, 25, 413–426. doi:10.1007/S10822-011-9428-Y
   PubMed Web of Science ®Google Scholar
• Lessene, G., Czabotar, P. E., & Colman, P. M. (2008). BCL-2 family antagonists for cancer therapy. Nature Reviews Drug Discovery, 7, 989–1000. doi:10.1038/nrd2658
   PubMed Web of Science ®Google Scholar
• Lessene, G., Czabotar, P. E., Sleebs, B. E., Zobel, K., Lowes, K. N., Adams, J. M., … Watson, K. G. (2013). Structure-guided design of a selective BCL-X(L) inhibitor. Nature Chemical Biology, 9, 390–397. doi:10.1038/nchembio.1246
   PubMed Web of Science ®Google Scholar
• Marimuthu, P., & Singaravelu, K. (2017). Deciphering the crucial residues involved in heterodimerization of bak peptide and anti-apoptotic proteins for apoptosis. Journal of Biomolecular Structure and Dynamics, 2, 1–12. doi: 10.1080/07391102.2017.1331863
   Google Scholar
• Marimuthu, P., Singaravelu, K., & Namasivayam, V. (2016). Probing the binding mechanism of mercaptoguanine derivatives as inhibitors of HPPK by docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 30, 1–15. doi:10.1080/07391102.2016.1260496
   Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8, 3314–3321. doi:10.1021/Ct300418 h
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30, 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Namasivayam, V., & Günther, R. (2007). pso@autodock: A fast flexible molecular docking program based on swarm intelligence. Chemical Biology & Drug Design, 70, 475–484. doi:10.1111/j.1747-0285.2007.00588.x
   PubMed Web of Science ®Google Scholar
• Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004). Structural biology of the Bcl-2 family of proteins. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, 1644, 83–94. doi:10.1016/j.bbamcr.2003.08.012
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., … Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26, 1781–1802. doi:10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Pulla, V. K., Sriram, D. S., Viswanadha, S., Sriram, D., & Yogeeswari, P. (2016). Energy-based pharmacophore and three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling combined with virtual screening to identify novel small-molecule inhibitors of silent mating-type information regulation 2 homologue 1 (SIRT1). Journal of Chemical Information and Modeling, 56, 173–187. doi:10.1021/acs.jcim.5b00220
   PubMed Web of Science ®Google Scholar
• Reed, J. C. (1995). Regulation of apoptosis by Bcl-2 family proteins and its role in cancer and chemoresistance. Current Opinion in Oncology, 7, 541–546.10.1097/00001622-199511000-00012
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E., 3rd (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9, 3084–3095. doi:10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Ryckaer, J., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23, 327–341. doi:10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., … Fesik, S. W. (1997). Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science, 275, 983–986. doi:10.1126/science.275.5302.983
   PubMed Web of Science ®Google Scholar
• Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24, 417–422. doi:10.1007/s10822-010-9352-6
   PubMed Web of Science ®Google Scholar
• Senthilkumar, R., Marimuthu, P., Paul, P., Manojkumar, Y., Arunachalam, S., Eriksson, J. E., & Johnson, M. S. (2016). Plasma protein binding of anisomelic acid: Spectroscopy and molecular dynamic simulations. Journal of Chemical Information and Modeling, 56, 2401–2412. doi:10.1021/acs.jcim.6b00445
   PubMed Web of Science ®Google Scholar
• Shivakumar, D., Williams, J., Wu, Y. J., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. Journal of Chemical Theory and Computation, 6, 1509–1519. doi:10.1021/Ct900587b
   PubMed Web of Science ®Google Scholar
• Sleebs, B. E., Kersten, W. J., Kulasegaram, S., Nikolakopoulos, G., Hatzis, E., Moss, R. M., … Lessene, G. (2013). Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL. Journal of Medicinal Chemistry, 56, 5514–5540. doi:10.1021/jm400556w
   PubMed Web of Science ®Google Scholar
• Tao, Z. F., Hasvold, L., Wang, L., Wang, X., Petros, A. M., Park, C. H., … Souers, A. J. (2014). Discovery of a potent and selective BCL-XL inhibitor with In vivo activity. ACS Medicinal Chemistry Letters, 5, 1088–1093. doi:10.1021/ml5001867
   PubMed Web of Science ®Google Scholar
• Tsui, V., & Case, D. A. (2000). Theory and applications of the generalized born solvation model in macromolecular simulations. Biopolymers, 56, 275–291. doi:10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157–1174. doi:10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54, 5.6.1–5.6.37. doi: 10.1002/cpbi.3
   PubMedGoogle Scholar
• Yip, K. W., & Reed, J. C. (2008). Bcl-2 family proteins and cancer. Oncogene, 27, 6398–6406. doi:10.1038/onc.2008.307
   PubMed Web of Science ®Google Scholar